DelveInsight’s “Anti-hypertension Market Insights, Epidemiology, and Market Forecast-2032“ report delivers an in-depth understanding of the Anti-hypertension, historical and forecasted epidemiology as well as the Anti-hypertension market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.
Key Highlights for Anti- Hypertension Market
-
Key companies working in Anti the hypertension market include AstraZeneca, Kitov Pharma and many others
-
Key therapies in the Anti- hypertension market include Felodipine, Hydrochlorothiazide, and many others.
-
The Market Size for Anti- Hypertension market is expected to be USD XX Million by 2032.
-
The CAGR for Anti- Hypertension market is expected to be XX%
Anti-Hypertension Overview
Antihypertensives are a class of drugs that are used to treat hypertension (high blood pressure). Antihypertensive therapy seeks to prevent the complications of high blood pressure, such as stroke, heart failure, kidney failure, and myocardial infarction. Evidence suggests that a reduction of blood pressure by 5 mmHg can decrease the risk of stroke by 34% and of ischaemic heart disease by 21%, and can reduce the likelihood of dementia, heart failure, and mortality from cardiovascular disease. There are many classes of antihypertensives, which lower blood pressure by different means. Among the most important and widely used medications are thiazide diuretics, calcium channel blockers, ACE inhibitors, angiotensin II receptor antagonists (ARBs), and beta blockers.
Click here to learn more about the Anti-Hypertension Market Landscape
The Report Covers the Anti-Hypertension Epidemiology Segmented by:
-
Anti-hypertension is a prevalent case
-
Anti-hypertension is diagnosed cases
-
Anti-hypertension is a treatment cases
-
Anti-hypertension is incident cases
Anti-Hypertension Market Outlook
The Anti-hypertension market outlook of the report helps to build a detailed comprehension of the historic, current, and forecasted Anti-hypertension market trends by analyzing the impact of current Anti-hypertension therapies on the market, unmet needs, drivers and barriers, and demand for better technology.
This segment gives a thorough detail of the Anti-hypertension market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated Anti-hypertension market data are presented with relevant tables and graphs to give a clear view of the market at first sight.
According to DelveInsight, the Anti-hypertension market in 7MM is expected to witness a major change in the study period 2019-2032.
Key Companies Working in the Anti-Hypertension Market
-
Kitov Pharma Ltd
-
AstraZeneca
And many others
Anti-Hypertension Therapies Covered and Analyzed in the Report
-
Felodipine
-
Hydrochlorothiazide
And many others
Learn more about the Key Companies and Emerging Therapies in the Anti-Hypertension Market
Table of Contents
-
Key Insights
-
Anti-Hypertension Introduction
-
Executive Summary of Anti-Hypertension –
-
Disease Background and Overview
-
Epidemiology and patient population
-
Anti-Hypertension Emerging Therapies
-
Anti-Hypertension Market Outlook
-
Market Access and Reimbursement of Therapies
-
Market Drivers
-
Market Barriers
-
Appendix
-
Report Methodology
-
DelveInsight Capabilities
-
Disclaimer
Learn about the detailed offerings of the report @ Anti-Hypertension Market Outlook
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Adya Kaul
Email: Send Email
Phone: 919650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/consulting/due-diligence-services